15th INTERNATIONAL CONGRESS OF PARKINSON'S

More documents

Recommendations

Info

Daily Schedule Thursday 54 Thursday, June 09, 2011 5103 Blue Ribbon Highlights 11:00 – 12:00 Location: South Building, Level 800, Hall FG Chairs: David Burn Newcastle upon Tyne, United Kingdom Susan H. Fox Toronto, ON, Canada This session will provide a critical review of the best poster presentations by a panel of experts, highlighting the relevance, novelty, and quality of both clinical and basic research presented by the delegates. Etienne Hirsch Paris, France Marcelo Merello Buenos Aires, Argentina At the conclusion of this session, participants should be better able to: 1. Understand the key new scientific findings from the poster presentations at the 2011 MDS International Congress 2. List the target areas of research focus for 2011-2012 3. Identify future primary areas of research in movement disorders Recommended Audience: Basic Scientists; Clinical Academicians; Practitioners; Non-Physician Health Professionals; Students/Residents/Trainees Corporate Therapeutic Symposia 12:00 – 12:40 Please see pages 62 -63 for more information Lunch will be provided for session attendees. Poster Session Poster Session 4 Location: South Building, Level 800, Hall E Abstracts: 908 - 1155 Poster Viewing: 9:00 – 18:00 Author Presentation: 13:30 – 15:00 Guided Poster Tours 13:30 – 15:00 Location: South Building, Level 800, Room 808 Guided Poster Tour 13 – Parkinson’s disease: Clinical trials Guided Poster Tour 14 – Huntington’s disease Guided Poster Tour 15 – Surgical therapy: Parkinson’s disease Guided Poster Tour 16 – Parkinson’s disease: Cognition For complete listing of abstracts in each tour, please see pages 76 -83. TICKET 5205 Parallel Session Fragile X Associated Tremor/Ataxia Syndrome [FXTAS] 15:00 – 17:00 Location: South Building, Level 700, Room 717AB Chairs: Deborah Hall Chicago, IL, USA David Riley South Euclid, OH, USA 15:00 Clinical features: Archetypes, formes frustes, and “gray zone” carriers, treatment strategies, and ongoing research perspectives Deborah Hall Chicago, IL, USA 15:40 Molecular basis of FXTAS and other Fragile X associated disorders Paul Hagerman Davis, CA, USA 16:20 Epidemiology, other Fragile X associated disorders, diagnostic testing, and genetic counseling Sébastien Jacquemont Lausanne, Switzerland At the conclusion of this session, participants should be better able to: 1. Understand the molecular biological basis of FXTAS and the relationship between FXTAS and other Fragile X associated disorders 2. List the core clinical features of FXTAS, neurological findings that differ between genders, and the clinical features of “gray zone” gene carriers 3. Identify patients most suitable for FXTAS genetic testing and genetic counseling Recommended Audience: Basic Scientists; Clinical Academicians; Practitioners; Non-Physician Health Professionals; Students/Residents/Trainees TICKET 5206 Parallel Session Genetic testing in Movement Disorders: Approaches and controversies 15:00 – 17:00 Location: South Building, Level 700, Room 714AB Chairs: Oksana Suchowersky Calgary, AB, Canada Vincenzo Bonifati Rotterdam, Netherlands 15:00 Approaches to genetic testing in movement disorders Andrea Nemeth Oxford, United Kingdom 15:40 Controversies in genetic testing in movement disorders Vincenzo Bonifati Rotterdam, Netherlands
Thursday, June 09, 2011 5206 Parallel Session 16:20 Genetic counseling in movement disorders Susan Bressman New York, NY, USA At the conclusion of this session, participants should be better able to: 1. Understand methods and approaches to genetic testing 2. Discuss controversial issues related to genetic testing 3. Understand the needs of patients receiving genetic testing Recommended Audience: Basic Scientists; Clinical Academicians; Practitioners; Non-Physician Health Professionals; Students/Residents/Trainees TICKET 5207 Parallel Session Human-derived cell lines to study pathogenesis of Parkinson’s disease 15:00 – 17:00 Location: South Building, Level 700, Room 713AB Chairs: Ted Dawson Baltimore, MD, USA Carolyn Sue Sydney, Australia 15:00 The value of human-derived cell lines in studying Parkinson’s disease Carolyn Sue Sydney, Australia 15:40 The use of skin fibroblasts to study pathogenesis of Parkinson’s disease Aleksandar Rakovic Lübeck, Germany 16:20 The use of induced pluripotent stem cells (iPS) as a Parkinson’s disease cell model Ole Isacson Belmont, MA, USA At the conclusion of this session, participants should be better able to: 1. Describe the use of cybrids, fibroblasts, and iPS cells as Parkinson’s disease cell models 2. Explain the differences, advantages and disadvantages of different human cellular disease models used to investigate Parkinson’s disease 3. Understand pathogenic mechanisms identified by new human cellular disease models of Parkinson’s disease Recommended Audience: Basic Scientists; Clinical Academicians 15 th INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS TICKET continued TICKET 5208 Parallel Session Pain and sensory disturbance in dystonia 15:00 – 17:00 Location: South Building, Level 700, Room 715AB Chairs: Kailash Bhatia London, United Kingdom Ruth Djaldetti Petah Tikva, Israel 15:00 Sensory abnormalities in dystonia: What we have learned from basic science Yoshikazu Ugawa Fukushima, Japan 15:40 Are sensory abnormalities relevant to the pathogenesis of dystonia? Michele Tinazzi Milan, Italy 16:20 Pain and dystonia: A clinical perspective Bob van Hilten Leiden, Netherlands At the conclusion of this session, participants should be better able to: 1. Describe the basic science evidence of sensory abnormalities in dystonia 2. Recognize the role played by sensory abnormalities in the pathogenesis of dystonia 3. Assess and manage patients with dystonia and pain Recommended Audience: Basic Scientists; Clinical Academicians; Practitioners; Students/Residents/Trainees Supported by an unrestricted educational grant from Ipsen. TICKET 5209 Parallel Session To sleep, perchance to dream: REM sleep behavior disorder and movement disorders 15:00 – 17:00 Location: South Building, Level 700, Room 716AB Chairs: Ali Rajput Saskatoon, SK, Canada Ron Postuma Montreal, QC, Canada 15:00 Pathophysiology of RBD: Is the “what” or the “where” that counts? Jean-François Gagnon Montreal, QC, Canada 15:40 What does RBD tell us about the Parkinson’s disease phenotype? Ron Postuma Montreal, QC, Canada 16:20 Advances in diagnosis and treatment of RBD Paul Reading Middlesbroug, United Kingdom 55 Daily Schedule Thursday
Page 2 and 3:
Claiming CME Credit To claim CME cr
Page 4 and 5:
2 Welcome Dear Colleagues and Frien
Page 6 and 7: About MDS 4 About MDS The Movement
Page 8 and 9: About MDS 6 About MDS Congress Loca
Page 10 and 11: MDS About Education MDS 8 Education
Page 12 and 13: MDS About Education MDS 10 Educatio
Page 14 and 15: MDS About Education MDS 12 Audio-Vi
Page 16 and 17: Membership About MDS 14 Connect wit
Page 18 and 19: Toronto Information About MDS 16 Do
Page 20 and 21: Toronto Information About MDS 18 To
Page 22 and 23: International Congress Information
Page 36 and 37: Daily Schedule 34 Session Definitio
Page 38 and 39: Daily Schedule Sunday Sunday and Mo
Page 40 and 41: Daily Schedule Monday 38 Monday, Ju
Page 42 and 43: Daily Schedule Monday 40 Monday, Ju
Page 44 and 45: Daily Schedule Monday and Tuesday t
Page 46 and 47: Daily Schedule Tuesday 44 Tuesday,
Page 48 and 49: Daily Schedule Tuesday 46 Tuesday,
Page 50 and 51: Daily Schedule Wednesday 48 Wednesd
Page 52 and 53: Daily Schedule Wednesday 50 Wednesd
Page 54 and 55: Daily Schedule Thursday 52 Wednesda
Page 58 and 59: Daily Schedule Thursday 56 Thursday
Page 60 and 61: Faculty Listing 58 Faculty Listing
Page 62 and 63: Faculty Listing 60 Faculty Listing
Page 64 and 65: Corporate Faculty Therapeutic Listi
Page 66 and 67: Leading Advances in DBS Patient Man
Page 68 and 69: This therapy is not for everyone. D
Page 70 and 71: Exhibits 68 Exhibitor Directory ABB
Page 72 and 73: Exhibits 70 Exhibitor Directory GE
Page 74 and 75: Exhibits 72 Exhibitor Directory MER
Page 76 and 77: Exhibits 74 Exhibitor Directory TEV
Page 78 and 79: Exhibits 76 Exhibitor Floor Plan
Page 80 and 81: Guided Poster Tours 78 Guided Poste
Page 88 and 89: Abstracts by topic 86 Abstracts by
Page 106 and 107:
Abstracts by topic 104 Abstracts by
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 131 and 132:
DBS | Advance A New Day in DBS The
show all

15th INTERNATIONAL CONGRESS OF PARKINSON'S

Create successful ePaper yourself

Delete template?

Save as template?